Stacker on MSN

Achieving lasting remission for HIV

Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial

Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The ...
Fierce Pharma

Gilead's single-tablet HIV combo of bictegravir, lenacapavir passes another late-stage test on way to filings

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...
Blavity on MSN

What causes facial changes when you’re HIV positive?

In recent years, public conversations about HIV have significantly shifted. Better testing, improved treatment and natural ...

Natural Human Protein Reactivates Dormant HIV, Bringing Scientists One Step Closer to a Cure

A natural vitamin A transporter, RBP4, can awaken latent HIV through NF-κB signalling, offering a new angle for cure strategies. Human immunodeficiency virus (HIV) is a virus that attacks key immune ...

New test distinguishes vaccine-induced false positives from active HIV infection

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes ...

Howard is among few places in Maryland offering a new shot to prevent HIV

Howard County will dispense the biannual prevention injection Yeztugo, a less time-consuming option than current preventative ...